Treatment of depression and anxiety in Parkinson’s Disease
|dc.contributor.supervisor||Dr Sarah Egan|
|dc.contributor.supervisor||Dr Andrea Loftus|
|dc.contributor.supervisor||Dr Natalie Gasson|
This thesis examined the treatment of depression and anxiety in Parkinson’s disease (PD) and comprised four studies. Study 1 was a meta-analysis of treatments for depression and anxiety in PD. Study 2 examined the validity of the DASS-21 as an assessment tool in PD. Study 3 was a randomised controlled trial of group CBT for depression and anxiety in PD. Study 4 was a cross-sectional cohort study examining mental health service utilisation and barriers to treatment.
|dc.title||Treatment of depression and anxiety in Parkinson’s Disease|
|curtin.department||School of Psychology and Speech Pathology, Faculty of Health Sciences|